Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

QiC Oncology

- PMLiVE

Lilly’s gastric cancer prospect clears phase III trial

Ramucirumab improved both overall and progress-free survival

Roche - Basel

Roche Q3 sales up on cancer drugs

And CEO Schwan commits to gene sequencing despite failed Illumina bid

Celgene’s Abraxane receives FDA approval in lung cancer

Adds to current breast cancer indication

NHS’ Jim Easton reportedly joining Care UK

HSJ says he has resigned as director of transformation at NHS Commissioning Board

UK homecare growth faces potential challenge from HCP resistance

More effort needed to explain benefits to medical staff in hospitals, NCHA conference told

AZ’s MedImmune partners with global cancer institutes

Will research combinations of immunotherapies

- PMLiVE

Patient access schemes likely to remain under VBP, says NICE

New and existing schemes expected to have place within UK’s new pricing environment

Roche: Scotland must improve cancer drug access

Pharma company's call comes as SMC decides not to recommend Avastin in ovarian cancer

Study shows Sanofi’s Zaltrap effective in colorectal cancer

Reinforces prospects following US approval

- PMLiVE

Less than half of UK healthcare professionals use mobile apps for work

Secondary care use higher than in primary care, according to Cegedim Strategic Data study

Daiichi and ArQule pull late-stage study of lung cancer drug

Fails to reach primary endpoint of overall survival

- PMLiVE

UK government launches Healthwatch England to champion patient voices

Will support public opinion in health and social care

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links